COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study

Basit Öğe Kaydı
dc.contributor.authorVigliar, Elena
dc.contributor.authorPisapia, Pasquale
dc.contributor.authorDello Iacovo, Filippo
dc.contributor.authorAlcaraz-Mateos, Eduardo
dc.contributor.authorAlì, Greta
dc.contributor.authorAli, Syed Z.
dc.contributor.authorBaloch, Zubair W.
dc.date.accessioned2024-10-29T17:43:24Z
dc.date.available2024-10-29T17:43:24Z
dc.date.issued2022
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractBackground: In a previous worldwide survey, the authors showed a drastic reduction in the number of cytological specimens processed during the coronavirus disease 2019 “lockdown” period along with an increase in malignancy rates. To assess the continued impact of the pandemic on cytological practices around the world, they undertook a second follow-up worldwide survey collecting data from the post-lockdown period (2020). Methods: Participants were asked to provide data regarding their cytopathology activity during the first 12 weeks of their respective national post-lockdown period (2020), which ranged from April 4 to October 31. Differences between the post-lockdown period and the corresponding 2019 period were evaluated, and the authors specifically focused on rates of malignant diagnoses. Results: A total of 29 respondents from 17 countries worldwide joined the survey. Overall, a lower number of cytological specimens (n = 236,352) were processed in comparison with the same period in 2019 (n = 321,466) for a relative reduction of 26.5%. The overall malignancy rate showed a statistically significant increase (12,442 [5.26%] vs 12,882 [4.01%]; P <.001) during the same time period. Similar results were obtained if both malignancy and suspicious for malignancy rates were considered together (15,759 [6.58%] vs 16,011 [4.98%]; P <.001). Conclusions: The data showed a persistent reduction in the cytological specimen volume during the post-lockdown period (2020). However, the relative increase in the cytological workload in the late part of the post-lockdown is a promising finding of a slow return to normality. © 2022 American Cancer Society.
dc.description.sponsorshipNational Institutes of Health, NIH; National Cancer Institute, NCI, (P30CA016672); National Cancer Institute, NCI; Boehringer Ingelheim
dc.identifier.doi10.1002/cncy.22547
dc.identifier.endpage351
dc.identifier.issn1934-662X
dc.identifier.issue5en_US
dc.identifier.pmid35006650
dc.identifier.scopus2-s2.0-85122709300
dc.identifier.scopusqualityQ1
dc.identifier.startpage344
dc.identifier.urihttps://doi.org/10.1002/cncy.22547
dc.identifier.urihttps://hdl.handle.net/20.500.11776/12321
dc.identifier.volume130
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofCancer Cytopathology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcancer screening program
dc.subjectcoronavirus disease 2019 (COVID-19)
dc.subjectcytopathology
dc.subjectfine-needle aspiration
dc.subjectmalignancy rate
dc.titleCOVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu